Header Logo

Connection

JOHN KIRKWOOD to Testicular Neoplasms

Back to Details
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Testicular Neoplasms.
JOHN KIRKWOOD
Connection Strength
0.163
Testicular Neoplasms
  1. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial. Lancet Oncol. 2022 11; 23(11):1378-1388.
    View in: PubMed
    Score: 0.163
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.